Alnylam, Medicines Co cholesterol drug effective for 6 months-study

ORLANDO, Nov 11 (Reuters) - An experimental cholesterol fighter being developed by Alnylam Pharmaceuticals and The Medicines Co slashed levels of bad LDL cholesterol and remained effective for six months, according to data from a small, early stage study.